Pharmaceutical logistics in May 2026 is defined by two critical challenges: the relentless radioactive decay of new oncology therapies and the severe global CO2 supply crisis.
Precision Delivery for Lutathera (Lu-177)
As Spain rapidly increases its radiopharmaceutical output, the «Last Mile» becomes the most critical phase of the entire supply chain.
For therapies like Lutathera (Lu-177), the absolute priority is minimizing transit time to prevent isotope decay. NBiopharma’s dedicated Class 7 routes operate against the atomic clock, ensuring that these life-saving doses reach hospitals precisely when needed, preserving the exact potency required for effective patient treatment.
Surviving the Dry Ice Shortage with VIP Technology
The rising cost and scarcity of CO2 are making traditional cryogenic logistics unsustainable for many operators.
How can we protect the integrity of clinical trials in this environment? The answer lies in advanced engineering. At NBiopharma, we utilize Vacuum Insulated Panels (VIP) to navigate this shortage. VIP technology allows clinical trials to continue seamlessly by doubling the thermal efficiency of the packaging, thereby drastically reducing the dependency on dry ice while maintaining strict cryogenic temperatures.